Table 5.

Immunocytochemical Reactivity of Nonhematopoietic Tumors for ALK Protein

TumorNo. Positive/Tested
Carcinoma 
Lung 0/11 
GI tract 0/12 
Breast 0/5 
Thyroid 0/6 
Pancreas 0/2 
Kidney 0/2 
Bladder 0/1 
Prostate 0/2 
Liver 0/3 
Uterus 0/1 
Sarcoma 
Liposarcoma 0/1 
Synovial sarcoma 0/1 
Leiomyosarcoma 0/1 
Rhabdomyosarcoma 0/2 
Others 
Carcinoid 0/7 
Pheochromocytoma 0/4 
Adrenocortical carcinoma 0/1 
Nephroblastoma 0/3 
Thymoma 0/3 
Neuroblastoma 0/2 
Ganglioneuroblastoma 0/2 
Melanoma 0/4 
Leiomyoma 0/1 
Oncocytoma 0/2 
Adenoma 0/1 
Total 0/80 
TumorNo. Positive/Tested
Carcinoma 
Lung 0/11 
GI tract 0/12 
Breast 0/5 
Thyroid 0/6 
Pancreas 0/2 
Kidney 0/2 
Bladder 0/1 
Prostate 0/2 
Liver 0/3 
Uterus 0/1 
Sarcoma 
Liposarcoma 0/1 
Synovial sarcoma 0/1 
Leiomyosarcoma 0/1 
Rhabdomyosarcoma 0/2 
Others 
Carcinoid 0/7 
Pheochromocytoma 0/4 
Adrenocortical carcinoma 0/1 
Nephroblastoma 0/3 
Thymoma 0/3 
Neuroblastoma 0/2 
Ganglioneuroblastoma 0/2 
Melanoma 0/4 
Leiomyoma 0/1 
Oncocytoma 0/2 
Adenoma 0/1 
Total 0/80 

All tissues were stained as cryostat sections with MoAb ALK1, as described in the text.

or Create an Account

Close Modal
Close Modal